BioCryst Pharmaceuticals
BCRX
#4609
Rank
ยฃ1.28 B
Marketcap
ยฃ6.21
Share price
2.39%
Change (1 day)
0.80%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Total debt

Total debt on the balance sheet as of June 2024 : ยฃ0.62 B

According to BioCryst Pharmaceuticals 's latest financial reports the company's total debt is ยฃ0.62 B. A companyโ€™s total debt is the sum of all current and non-current debts.

BioCryst Pharmaceuticals - Total debt on balance sheet (from 1996 to 2024)

Total debt by year

Year Total debt Change
2023-12-31ยฃ0.64 B5.68%
2022-12-31ยฃ0.61 B39.82%
2021-12-31ยฃ0.43 B114.1%
2020-12-31ยฃ0.20 B220.96%
2019-12-31ยฃ63.79 M31.66%
2018-12-31ยฃ48.45 M19.67%
2017-12-31ยฃ40.48 M-7.01%
2016-12-31ยฃ43.53 M114.02%
2015-12-31ยฃ20.34 M5.56%
2014-12-31ยฃ19.27 M6.09%
2013-12-31ยฃ18.16 M-2.09%
2012-12-31ยฃ18.55 M-3.88%
2011-12-31ยฃ19.3 M
2000-12-31ยฃ0 M
1997-12-31ยฃ0.06 M-65.25%
1996-12-31ยฃ0.17 M

Total debt for similar companies or competitors

Company Total debt differencediff. Country
ยฃ0.56 B-9.59%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.04 B 66.72%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.14 M-99.82%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.17 B-71.61%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ17.79 B 2,741.78%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.81 M-99.71%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ16.33 B 2,508.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ0.65 B 4.93%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ9.24 M-98.52%๐Ÿ‡บ๐Ÿ‡ธ USA